Differentiation potential of human muscle-derived cells towards chondrogenic phenotype in alginate beads culture

Osteoarthritis and Cartilage

Volumn 16, Issue 12, 2008, Pages 1509-1518

  Andriamanalijaona, R ^a   Duval, E ^a   Raoudi, M ^a   Lecourt, S ^b   Vilquin, J T ^b   Marolleau, J P ^c   Pujol, J P ^a   Galera, P ^a   Boumediene, K ^a  

^a Biology and Innovative Therapeutics for Ovarian Cancers group   (France)

^b INSERM   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Alginate; Chondrogenesis; Muscle derived cells; TGF 1

Indexed keywords

AGGRECAN; ALCIAN BLUE; ALGINIC ACID; CD56 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHONDROGENESIS; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TISSUE REGENERATION; TISSUE REPAIR; WESTERN BLOTTING;

ALGINATES; ANTIGENS, CD56; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLE, SKELETAL; PHENOTYPE;

EID: 55549147888     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.04.018     Document Type: Article

References (79)

1. Hangody L., Kish G., Karpati Z., Udvarhelyi I., Szigeti I., and Bely M. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics 121 (1998) 751-756
2. Brittberg M. Autologous chondrocyte transplantation. Clin Orthop Relat Res 367 Suppl (1999) 147-155
3. O'Driscoll S.W. Articular cartilage regeneration using periosteum. Clin Orthop Relat Res 367 Suppl (1999) 186-203
4. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., and Pittenger M. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4 (1998) 415-428
5. Barry F., Boynton R.E., Liu B., and Murphy J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 268 (2001) 189-200
6. Sakaguchi Y., Sekiya I., Yagishita K., and Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arhtritis Rheum 52 (2005) 2521-2529
7. Jackson K.A., Mi T., and Goodell M.A. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A 96 (1999) 14482-14486
8. Bosch P., Musgrave D.S., Lee J.Y., Cummins J., Shuler T., Ghivizzani T.C., et al. Osteoprogenitor cells within skeletal muscle. J Orthop Res 18 (2000) 933-944
9. Lee J.Y., Qu-Peterson, Cao B., Kimura S., Jankowski R.J., Cummins J., et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150 (2000) 1085-1100
10. Cao B., Zheng B., Jankowski R.J., Kimura S., Ikezawa M., Deasy B., et al. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol 5 (2003) 640-646
11. Young H.E., Steele T.A., Bray R.A., Detmer K., Blake L.W., Lucas P.W., et al. Human pluripotent and progenitor cells display cell surface cluster differentiation markers CD10, CD13, CD56, and MHC class-I. Proc Soc Exp Biol Med 221 (1999) 63-71
12. Wada M.R., Inagawa-Ogashiwa M., Shimizu S., Yasumoto S., and Hashimoto N. Generation of different fates from multipotent muscle stem cells. Development 129 (2002) 2987-2995
13. Vourc'h P., Romero-Ramos M., Chivatakarn O., Young H.E., Lucas P.A., El-Kalay M., et al. Isolation and characterization of cells with neurogenic potential from adult skeletal muscle. Biochem Biophys Res Commun 31 (2004) 893-901
14. Shefer G., Wleklinski-Lee M., and Yablonka-Reuveni Z. Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway. J Cell Sci 117 (2004) 5393-5404
15. Sinanan A.C., Hunt N.P., and Lewis M.P. Human adult craniofacial muscle-derived cells: neural-cell adhesion-molecule (NCAM; CD56)-expressing cells appear to contain multipotential stem cells. Biotechnol Appl Biochem 40 (2004) 25-34
16. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122 (2005) 289-301
17. Torrente Y., Tremblay J.P., Pisati F., Belicchi M., Rossi B., Sironi M., et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol 152 (2000) 335-348
18. Mastrogiacomo M., Derubeis A.R., and Cancedda R. Bone and cartilage formation by skeletal muscle derived cells. J Cell Physiol 204 (2005) 594-603
19. Cerletti M., Molloy M.J., Tomczak K.K., Yoon S., Ramoni M.F., Kho A.T., et al. Melanoma cell adhesion molecule is a novel marker for human fetal myogenic cells and affects myoblast fusion. J Cell Sci 119 (2006) 3117-3127
20. Dellavalle A., Sampaolesi M., Tonlorenzi R., Tagliafico E., Sacchetti B., Perani L., et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9 (2007) 255-267
21. Williams J.T., Southerland S.S., Souza J., Calcutt A.F., and Cartledge R.G. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 65 (1999) 22-26
22. Young H.E., Steele T.A., Bray R.A., Hudson J., Floyd J.A., Hawkins K., et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264 (2001) 51-62
23. Levy M.M., Joyner C.J., Virdi A.S., Reed A., Triffitt J.T., Simpson A.H., et al. Osteoprogenitor cells of mature human skeletal muscle tissue: an in vitro study. Bone 29 (2001) 317-322
24. De Coppi P., Milan G., Scarda A., Boldrin L., Centobene C., Piccoli M., et al. Rosiglitazone modifies the adipogenic potential of human muscle satellite cells. Diabetologia 49 (2006) 1962-1973
25. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
26. Adachi N., Sato K., Usas A., Fu F.H., Ochi M., Han C.W., et al. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol 29 (2002) 1920-1930
27. Kuroda R., Usas A., Kubo S., Corsi K., Peng H., Rose T., et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 54 (2006) 433-442
28. Asakura A., Komaki M., and Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68 (2001) 245-253
29. Lequerica J.L., Mirabet V., Montero J.A., Hurtado C., Piquer S., and Carbonell F. In vitro proliferation, differentiation and immuno-magnetic bead purification of human myoblasts. Ann Transplant 4 (1999) 103-108
30. Ham R.G., St Clair J.A., Webster C., and Blau H.M. Improved media for normal human muscle satellite cells: serum-free clonal growth and enhanced growth with low serum. In Vitro Cell Dev Biol 24 (1988) 833-844
31. Baj A., Bettaccini A.A., Casalone R., Sala A., Cherubino P., and Toniolo A.Q. Culture of skeletal myoblasts from human donors aged over 40 years: dynamics of cell growth and expression of differentiation markers. J Transl Med 3 (2005) 21 (1-10)
32. Vilquin J.T., Marolleau J.P., Sacconi S., Garcin I., Lacassagne M.N., Robert I., et al. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients. Gene Ther 12 (2005) 1651-1662
33. Menasché P., Hagège A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., et al. First successful clinical myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
34. Skuk D., Roy B., Goulet M., Chapdelaine P., Bouchard J.P., Roy R., et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 9 (2004) 475-482
35. Vilquin J.T. Myoblast transplantation: clinical trials and perspectives. Mini-review. Acta Myol XXIV (2005) 119-127
36. Strasser H., Marksteiner R., Margreiter E., Pinggera G.M., Mitterberger M., Frauscher F., et al. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial. Lancet 369 (2007) 2179-2186
37. Schubert W., Zimmermann K., Cramer M., and Starzinski-Powitz A. Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle. Proc Natl Acad Sci U S A 86 1 (Jan 1989) 307-311
38. Lanier L.L., Testi R., Bindl J., and Phillips J.H. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 169 6 (1 Jun 1989) 2233-2238
39. Illa I., Leon-Monzon M., and Dalakas M.C. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells. Ann Neurol 31 1 (Jan 1992) 46-52
40. Dreyer H.C., Blanco C.E., Sattler F.R., Schroeder E.T., and Wiswell R.A. Satellite cell numbers in young and older men 24 hours after eccentric exercise. Muscle Nerve 33 (2006) 242-253
41. Webster C., Pavlath G.K., Parks D.R., Walsh F.S., and Blau H.M. Isolation of human myoblasts with the fluorescence-activated cell sorter. Exp Cell Res 174 1 (Jan 1988) 252-265
42. Blau H.M., Webster C., and Pavlath G.K. Purification and proliferation of human myoblasts isolated with fluorescence activated cell sorting. Adv Exp Med Biol 280 (1990) 97-100
43. Belles-Isles M., Roy R., Dansereau G., Goulet M., Roy B., Bouchard J.P., et al. Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. Eur J Histochem 37 4 (1993) 375-380
44. Skuk D., Goulet M., Roy B., Chapdelaine P., Bouchard J.P., Roy R., et al. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 65 4 (Apr 2006) 371-386
45. Menasché P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 9 (4 Mar 2008) 1189-1200
46. Yamaguchi A. Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily. Semin Cell Biol 6 (1995) 165-173
47. Hunziker E.B., Driesang I.M., and Morris E.A. Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily. Clin Orthop Relat Res 391 Suppl (2001) 171-181
48. Ma H.L., Chen T.H., Low-Tone Ho L., and Hung S.C. Neocartilage from human mesenchymal stem cells in alginate: implied timing of transplantation. J Biomed Mater Res A 74 (2005) 439-446
49. Le Ricousse-Roussanne S., Larghero J., Zini J.M., Barateau V., Foubert P., Uzan G., et al. Ex vivo generation of mature and functional human smooth muscle cells differentiated from skeletal myoblasts. Exp Cell Res 313 7 (2007) 1337-1346
50. Andriamanalijaona R., Felisaz N., Kim S.J., King-Jones K., Lehmann M., Pujol J.P., et al. AP-4 transcription factor mediates interleukin-1β-induced Transforming Growth Factor-β1 (TGFβ1) expression in bovine articular chondrocytes. Arthritis Rheum 48 (2003) 1569-1581
51. Katagiri T., Akiyama S., Namiki M., Komaki M., Yamaguchi A., Rosen V., et al. Bone morphogenetic protein-2 converts differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127 (1994) 1755-1766
52. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401 (1999) 390-394
53. Qu-Peterson Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Boil 157 (2002) 851-864
54. Muraglia A., Corsi A., Riminucci M., Mastrogiacomo M., Cancedda R., Bianco P., et al. Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci 116 (2003) 2949-2955
55. Mwale F., Stachura D., Roughley P., and Antoniou J. Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. J Orthop Res 24 (2006) 1791-1798
56. Sandell L.J., Nalin A.M., and Reife R.A. Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev Dyn 199 (1994) 29-40
57. Valcourt U., Gouttenoire J., Aubert-Foucher E., Herbage D., and Mallein-Gerin F. Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1. FEBS Lett 545 (2003) 115-119
58. Paige K.T., Cima L.G., Yaremchuk M.J., Schloo B.L., Vacanti J.P., and Vacanti C.A. De novo cartilage generation using calcium alginate-chondrocyte constructs. Plast Reconstr Surg 97 (1996) 168-180
59. Demoor-Fossard M., Boittin M., Redini F., and Pujol J.P. Differential effects of interleukin-1 and transforming growth factor beta on the synthesis of small proteoglycans by rabbit articular chondrocytes cultured in alginate beads as compared to monolayers. Mol Cell Biochem 199 (1999) 69-80
60. Steinert A., Weber M., Dimmler A., Julius C., Schutze N., Noth U., et al. Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh-viscosity alginate. J Orthop Res 21 (2003) 1090-1097
61. Sandell L.J., and Daniel J.C. Effects of ascorbic acid on collagen mRNA levels in short term chondrocyte cultures. Connect Tissue Res 17 (1988) 11-22
62. Venezian R., Shenker B.J., Datar S., and Leboy P.S. Modulation of chondrocyte proliferation by ascorbic acid and BMP-2. J Cell Physiol 174 (1998) 331-341
63. Shapiro I.M., Leboy P.S., Tokuoka T., Forbes E., DeBolt K., Adams S.L., et al. Ascorbic acid regulates multiple metabolic activities of cartilage cells. Am J Clin Nutr 54 (1991) 1209-1213
64. Farquharson C., Berry J.L., Mawer E.B., Seawright E., and Whitehead C.C. Ascorbic acid-induced chondrocyte terminal differentiation: the role of the extracellular matrix and 1,25-dihydroxyvitamin D. Eur J Cell Biol 76 (1998) 110-118
65. Lanske B., Karaplis A.C., Lee K., Luz A., Vortkamp A., Pirro A., et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273 (1999) 663-666
66. Vortkamp A., Lee K., Lanske B., Segre G.V., Kronenberg H.M., and Tabin C.J. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273 (1996) 613-622
67. St-Jacques B., Hammerschmidt M., and McMahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13 (1999) 2072-2086
68. Chung U.I., Schipani E., McMahon A.P., and Kronenberg H.M. Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest 107 (2001) 295-304
69. Jimenez M.J., Balbin M., Lopez J.M., Alvarez J., Komori T., and Lopez-Otin C. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19 (1999) 4431-4442
70. Zelzer E., Glotzer D.J., Hartmann C., Thomas D., Fukai N., Soker S., et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106 (2001) 97-106
71. Zheng Q., Zhou G., Morello R., Chen Y., Garcia-Rojas X., and Lee B. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 162 (2003) 833-842
72. Beier F., Vornehm S., Poschl E., von der Mark K., and Lammi M.J. Localization of silencer and enhancer elements in the human type X collagen gene. J Cell Biochem 66 (1997) 210-218
73. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
74. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
75. Gersbach C.A., Byers B.A., Pavlath G.K., and Garcia A.J. Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp Cell Res 300 (2004) 406-417
76. Serra R., and Chang C. TGF-beta signaling in human skeletal and patterning disorders. Birth Defects Res C Embryo Today 69 (2003) 333-351
77. Lieb E., Vogel T., Milz S., Dauner M., and Schulz M.B. Effects of transforming growth factor beta1 on bonelike tissue formation in three-dimensional cell culture. II: osteoblastic differentiation. Tissue Eng 10 (2004) 1414-1425
78. Ferguson C.M., Schwarz E.M., Reynolds P.R., Puzas J.E., Rosier R.N., and O'Keefe R.J. Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation. Endocrinology 141 (2000) 4728-4735
79. Kawamura K., Chu C.R., Sobajima S., Robbins P.D., Fu F.H., Izzo N.J., et al. Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures. Exp Hematol 33 (2005) 865-872